approval
saveKADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval
community read0 votes
Sponsor: GENENTECH. Form: VIAL. Route: SINGLE-USE
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalKADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalMay 14, 2025 · 508d ago
- approvalKADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalFeb 2, 2022 · 1705d ago
- approvalKADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalSep 27, 2020 · 2198d ago
- approvalKADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalMay 3, 2019 · 2711d ago
- approvalKADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalDec 18, 2018 · 2847d ago
- approvalKADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalSep 20, 2018 · 2936d ago
- approvalKADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalJul 25, 2016 · 3723d ago
- approvalKADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalApr 28, 2016 · 3811d ago
same company · ±60 days · 5
- approvalpolatuzumab vedotin: POLIVY (POLATUZUMAB VEDOTIN-PIIQ) — FDA approvalMar 18, 2026
- approvalfaricimab: VABYSMO (FARICIMAB-SVOA) — FDA approvalApr 9, 2026
- approvalinavolisib: ITOVEBI (INAVOLISIB) — FDA approvalApr 15, 2026
- approvalEVRYSDI: EVRYSDI (RISDIPLAM) — FDA approvalFeb 10, 2026
- approvalEVRYSDI: EVRYSDI (RISDIPLAM) — FDA approvalFeb 10, 2026
comments(0)
5-min edit window · permanent after that